Intact Investment Management’s CVS Health CVS Stock Holding History

Intact Investment Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Sell	144,300 -35,400	-20%	-$3.16M	0.42%	60
2026 Q1	$12.9M	Buy	179,700 +14,400	+9%	+$1.11M	0.37%	71
2025 Q4	$13.1M	Sell	165,300 -12,500	-7%	-$985K	0.38%	66
2025 Q3	$13.4M	Sell	177,800 -21,000	-11%	-$1.44M	0.41%	58
2025 Q2	$13.7M	Sell	198,800 -20,100	-9%	-$1.32M	0.46%	57
2025 Q1	$14.8M	Sell	218,900 -55,100	-20%	-$3.3M	0.51%	54
2024 Q4	$12.3M	Buy	274,000 +193,600	+241%	+$10.9M	0.43%	61
2024 Q3	$5.06M	Sell	80,400 -1,200	-1%	-$70K	0.17%	134
2024 Q2	$4.82M	Buy	81,600 +47,800	+141%	+$2.99M	0.18%	121
2024 Q1	$2.7M	Sell	33,800 -52,500	-61%	-$4.01M	0.11%	160
2023 Q4	$6.81M	Sell	86,300 -54,000	-38%	-$3.84M	0.28%	87
2023 Q3	$9.8M	Sell	140,300 -12,300	-8%	-$872K	0.42%	52
2023 Q2	$10.5M	Buy	152,600 +49,400	+48%	+$3.51M	0.43%	48
2023 Q1	$7.67M	Buy	103,200 +11,000	+12%	+$922K	0.32%	83
2022 Q4	$8.59M	Sell	92,200 -13,800	-13%	-$1.33M	0.37%	71
2022 Q3	$10.1M	Buy	106,000 +23,700	+29%	+$2.35M	0.33%	64
2022 Q2	$7.63M	Buy	82,300 +19,300	+31%	+$1.88M	0.24%	86
2022 Q1	$6.38M	Sell	63,000 -69,500	-52%	-$7.3M	0.16%	108
2021 Q4	$13.7M	Sell	132,500 -11,200	-8%	-$1.03M	0.35%	64
2021 Q3	$12.2M	Buy	143,700 +2,900	+2%	+$243K	0.34%	64
2021 Q2	$11.7M	Hold	140,800	–	–	0.33%	69
2021 Q1	$10.6M	Buy	140,800 +10,500	+8%	+$765K	0.32%	68
2020 Q4	$8.9M	Sell	130,300 -18,800	-13%	-$1.22M	0.29%	76
2020 Q3	$8.7M	Buy	149,100 +5,000	+3%	+$311K	0.3%	69
2020 Q2	$9.36M	Buy	144,100 +19,600	+16%	+$1.23M	0.35%	59
2020 Q1	$7.39M	Sell	124,500 -20,300	-14%	-$1.36M	0.32%	68
2019 Q4	$10.8M	Buy	144,800 +5,100	+4%	+$358K	0.37%	59
2019 Q3	$8.81M	Hold	139,700	–	–	0.31%	65
2019 Q2	$7.61M	Sell	139,700 -4,400	-3%	-$237K	0.27%	73
2019 Q1	$7.77M	Buy	144,100 +700	+0.5%	+$43.2K	0.28%	73
2018 Q4	$9.4M	Hold	143,400	–	–	0.38%	56
2018 Q3	$11.3M	Sell	143,400 -2,000	-1%	-$143K	0.4%	49
2018 Q2	$9.36M	Sell	145,400 -3,000	-2%	-$198K	0.34%	62
2018 Q1	$9.23M	Buy	148,400 +119,200	+408%	+$8.55M	0.36%	58
2017 Q4	$2.12M	Hold	29,200	–	–	0.09%	106
2017 Q3	$2.37M	Sell	29,200 -1,600	-5%	-$127K	0.1%	96
2017 Q2	$2.48M	Sell	30,800 -1,000	-3%	-$79K	0.11%	88
2017 Q1	$2.5M	Sell	31,800 -17,200	-35%	-$1.37M	0.1%	94
2016 Q4	$3.87M	Buy	49,000 +900	+2%	+$72.8K	0.14%	88
2016 Q3	$4.28M	Buy	48,100 +1,500	+3%	+$142K	0.16%	86
2016 Q2	$4.46M	Buy	46,600 +7,100	+18%	+$708K	0.18%	79
2016 Q1	$4.09M	Sell	39,500 -1,000	-2%	-$97.2K	0.17%	84
2015 Q4	$3.96M	Buy	40,500 +6,400	+19%	+$627K	0.18%	82
2015 Q3	$3.29M	Buy	34,100 +200	+0.6%	+$21K	0.15%	95
2015 Q2	$3.55M	Buy	33,900 +7,900	+30%	+$807K	0.15%	96
2015 Q1	$2.68M	Sell	26,000 -4,700	-15%	-$476K	0.11%	107
2014 Q4	$2.96M	Buy	30,700 +9,100	+42%	+$802K	0.12%	101
2014 Q3	$1.72M	Buy	21,600 +3,900	+22%	+$307K	0.07%	109
2014 Q2	$1.33M	Hold	17,700	–	–	0.05%	95
2014 Q1	$1.32M	Buy	17,700 +200	+1%	+$14.1K	0.06%	98
2013 Q4	$1.25M	Sell	17,500 -1,200	-6%	-$77.1K	0.06%	89
2013 Q3	$1.06M	Buy	18,700 +13,500	+260%	+$804K	0.06%	91
2013 Q2	$297K	Buy	+5,200	New	+$301K	0.02%	102

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Intact Investment Management's CVS Position: Q2 2026 in Review

Intact Investment Management reduced its CVS Health (CVS) stake by 20% in Q2 2026, selling an estimated $3.16M and leaving 144,300 shares worth $14.9M. The position accounts for 0.42% of the portfolio, ranked #60.

Intact Investment Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Intact Investment Management held 144,300 shares of CVS Health worth $14.9M as of Q2 2026.
Intact Investment Management sold 35,400 CVS Health shares in Q2 2026, an estimated $3.16M.
CVS Health made up 0.42% of Intact Investment Management's portfolio in Q2 2026, its #60 holding.
Intact Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.